News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
652,937 Results
Type
Article (53785)
Company Profile (264)
Press Release (598888)
Multimedia
Podcasts (67)
Webinars (9)
Section
Business (179087)
Career Advice (2589)
Deals (32626)
Drug Delivery (106)
Drug Development (80961)
Employer Resources (147)
FDA (16754)
Job Trends (14181)
News (317620)
Policy (32457)
Tag
Academia (2791)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (88)
Alliances (48007)
ALS (99)
Alzheimer's disease (1500)
Antibody-drug conjugate (ADC) (135)
Approvals (16740)
Artificial intelligence (271)
Autoimmune disease (29)
Automation (15)
Bankruptcy (340)
Best Places to Work (11469)
BIOSECURE Act (21)
Biosimilars (111)
Biotechnology (189)
Bladder cancer (82)
Brain cancer (31)
Breast cancer (293)
Cancer (2360)
Cardiovascular disease (200)
Career advice (2173)
Career pathing (30)
CAR-T (163)
Cell therapy (464)
Cervical cancer (21)
Clinical research (65698)
Collaboration (873)
Company closure (1)
Compensation (430)
Complete response letters (26)
COVID-19 (2731)
CRISPR (46)
C-suite (246)
Cystic fibrosis (109)
Data (2297)
Decentralized trials (2)
Denatured (18)
Depression (50)
Diabetes (280)
Diagnostics (6294)
Digital health (17)
Diversity (6)
Diversity, equity & inclusion (34)
Drug discovery (129)
Drug pricing (110)
Drug shortages (26)
Duchenne muscular dystrophy (102)
Earnings (68360)
Editorial (43)
Employer branding (18)
Employer resources (129)
Events (93252)
Executive appointments (749)
FDA (18115)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (783)
Gene editing (116)
Generative AI (26)
Gene therapy (344)
GLP-1 (752)
Government (4667)
Grass and pollen (5)
Guidances (107)
Healthcare (18555)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (143)
Indications (29)
Infectious disease (2893)
Inflammatory bowel disease (159)
Inflation Reduction Act (7)
Influenza (55)
Intellectual property (102)
Interviews (489)
IPO (15450)
IRA (40)
Job creations (3181)
Job search strategy (1796)
Kidney cancer (11)
Labor market (30)
Layoffs (441)
Leadership (22)
Legal (7010)
Liver cancer (77)
Lung cancer (336)
Lymphoma (153)
Machine learning (8)
Management (51)
Manufacturing (306)
MASH (76)
Medical device (12262)
Medtech (12265)
Mergers & acquisitions (17730)
Metabolic disorders (720)
Multiple sclerosis (87)
NASH (22)
Neurodegenerative disease (115)
Neuropsychiatric disorders (29)
Neuroscience (2095)
NextGen: Class of 2025 (6560)
Non-profit (4923)
Now hiring (19)
Obesity (375)
Opinion (249)
Ovarian cancer (77)
Pain (96)
Pancreatic cancer (89)
Parkinson's disease (162)
Partnered (22)
Patents (246)
Patient recruitment (118)
Peanut (47)
People (52888)
Pharmaceutical (67)
Pharmacy benefit managers (19)
Phase I (20316)
Phase II (28917)
Phase III (21784)
Pipeline (1287)
Policy (152)
Postmarket research (2533)
Preclinical (8764)
Press Release (55)
Prostate cancer (109)
Psychedelics (34)
Radiopharmaceuticals (238)
Rare diseases (428)
Real estate (5027)
Recruiting (63)
Regulatory (23022)
Reports (29)
Research institute (2507)
Resumes & cover letters (431)
Rett syndrome (5)
RNA editing (5)
RSV (47)
Schizophrenia (81)
Series A (131)
Series B (88)
Service/supplier (4)
Sickle cell disease (58)
Special edition (16)
Spinal muscular atrophy (163)
Sponsored (31)
Startups (3418)
State (2)
Stomach cancer (11)
Supply chain (66)
Tariffs (39)
The Weekly (47)
Vaccines (780)
Venture capitalists (39)
Weight loss (244)
Women's health (33)
Worklife (16)
Date
Today (267)
Last 7 days (816)
Last 30 days (2827)
Last 365 days (32250)
2025 (11123)
2024 (34572)
2023 (38864)
2022 (49805)
2021 (54219)
2020 (52871)
2019 (45697)
2018 (34668)
2017 (31450)
2016 (30513)
2015 (35273)
2014 (27719)
2013 (23350)
2012 (24752)
2011 (25410)
2010 (23952)
Location
Africa (889)
Alabama (52)
Alaska (6)
Arizona (165)
Arkansas (12)
Asia (39524)
Australia (6752)
California (5952)
Canada (1960)
China (541)
Colorado (264)
Connecticut (284)
Delaware (134)
Europe (88366)
Florida (885)
Georgia (188)
Idaho (56)
Illinois (540)
India (24)
Indiana (300)
Iowa (9)
Japan (165)
Kansas (100)
Kentucky (22)
Louisiana (14)
Maine (60)
Maryland (893)
Massachusetts (4518)
Michigan (220)
Minnesota (344)
Mississippi (2)
Missouri (84)
Montana (31)
Nebraska (25)
Nevada (63)
New Hampshire (62)
New Jersey (1735)
New Mexico (23)
New York (1743)
North Carolina (989)
North Dakota (8)
Northern California (2603)
Ohio (209)
Oklahoma (14)
Oregon (37)
Pennsylvania (1336)
Puerto Rico (13)
Rhode Island (28)
South America (1139)
South Carolina (26)
South Dakota (1)
Southern California (2228)
Tennessee (95)
Texas (911)
United States (22700)
Utah (183)
Virginia (160)
Washington D.C. (66)
Washington State (544)
West Virginia (2)
Wisconsin (51)
652,937 Results for "national foundation for infectious diseases".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting
April 11, 2025
·
7 min read
Press Releases
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
February 6, 2025
·
12 min read
Press Releases
Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
April 7, 2025
·
5 min read
Press Releases
Eascra Biotech Receives U.S. National Science Foundation Grant
April 21, 2025
·
2 min read
Genetown
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell.
March 7, 2024
·
4 min read
Press Releases
Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)
October 1, 2024
·
6 min read
Press Releases
Biotia Announces Collaboration with Mayo Clinic to Advance Microbial Identification for Infectious Disease Diagnostics
April 3, 2025
·
2 min read
Press Releases
Vast Granted Qualified Infectious Disease Product Designation from the FDA
March 26, 2025
·
3 min read
Press Releases
Gylden’s 2025 Strategic Priorities for Advancing Innovative and Transformative Solutions for Infectious Diseases
February 25, 2025
·
7 min read
Drug Development
Traverse Biotech Awarded Phase I SBIR Grant by the National Institute of Allergy and Infectious Diseases for Development of Innate Immune Stimulator
Traverse Biotech, Inc. has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.
May 1, 2024
·
1 min read
1 of 65,294
Next
